The administration pushed insurers to sign a voluntary pledge to cut back on prior authorizations and simplify the process, ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Senate version of Trump’s tax-cut bill “poses an existential threat to our hospitals and to the Medicaid and Medicare ...

Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

The number of abortions in the U.S. rose again in 2024, with women continuing to find ways to get them despite bans and ...

WASHINGTON — Senate Republicans are considering adding a provision to President Trump’s tax cut bill that would further cut ...

But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the ...

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...

And more health news stories you need to start your week.